Headlines about Transenterix (NYSE:TRXC) have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Transenterix earned a daily sentiment score of 0.15 on Accern’s scale. Accern also gave media stories about the medical instruments supplier an impact score of 46.1121256233359 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Here are some of the media stories that may have impacted Accern’s analysis:
Are Options Traders Betting on a Big Move in TransEnterix (TRXC) Stock? (zacks.com)
TransEnterix, Inc. (NYSE:TRXC) - P/E Ratio Analysis – Nasdaq Journal (press release) (nasdaqjournal.com)
Head-To-Head Analysis: K2M Group Holdings (KTWO) versus Transenterix (TRXC) (americanbankingnews.com)
Beta Factor Analysis - TransEnterix, Inc., (NYSE: TRXC) – Stock Watch (stocksnewstimes.com)
Study Finds Laparoscopic Surgical Robots Offer No Clinical Benefit. Will It Hurt TransEnterix Sales? – Seeking Alpha (seekingalpha.com)
Separately, Stifel Nicolaus raised their target price on Transenterix from $3.75 to $4.00 and gave the stock a “buy†rating in a research report on Tuesday, October 31st.
::Thanks for sharing this link::
Stay protected from viruses and hackers. Download Avast at
https://goo.gl/S5BzjdLinkback:
https://tubagbohol.mikeligalig.com/index.php?topic=87990.0
Topic: Accern Sentiment Analysis Report (Read 812 times)